Tumors produce glucocorticoids by metabolite recycling, not synthesis, and activate Tregs to promote growth
Glucocorticoids are steroid hormones with potent immunosuppressive properties. Their primary source is the adrenals, where they are generated via de novo synthesis from cholesterol. In addition, many tissues have a recycling pathway in which glucocorticoids are regenerated from inactive metabolites...
Main Authors: | Matthew D. Taves, Shizuka Otsuka, Michaela A. Taylor, Kaitlynn M. Donahue, Thomas J. Meyer, Margaret C. Cam, Jonathan D. Ashwell |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2023-09-01
|
Series: | The Journal of Clinical Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1172/JCI164599 |
Similar Items
-
Biosynthesis of glucocorticoids in tumors. Reply.
by: Matthew D. Taves, et al.
Published: (2023-11-01) -
Dormant tumors circumvent tumor-specific adaptive immunity by establishing a Treg-dominated niche via DKK3
by: Timothy N. Trotter, et al.
Published: (2023-11-01) -
IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models
by: Janneke E. Jaspers, et al.
Published: (2023-05-01) -
An immunosuppressed microenvironment distinguishes lateral ventricle–contacting glioblastomas
by: Todd Bartkowiak, et al.
Published: (2023-06-01) -
Plasma cells in human pancreatic ductal adenocarcinoma secrete antibodies against self-antigens
by: Min Yao, et al.
Published: (2023-11-01)